Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio

Company Overview - Johnson & Johnson (J&J) is a leading company in the multitrillion-dollar global healthcare industry, with total healthcare spending in the U.S. surpassing $5.3 trillion in 2024 and growing at mid- to high single-digit rates [3] - The company develops and sells a wide range of pharmaceutical drugs and medical devices, with over 75% of its sales coming from products that hold top-two market share positions in their respective applications [4] Financial Strength - J&J has a strong financial position, allowing it to invest in new product development, acquire emerging competitors, and consistently raise its dividend [5] - The stock currently yields 2.1%, with management having raised the dividend for 63 consecutive years, making it a reliable income source for investors [6] - J&J is one of only two companies with the highest available credit rating (AAA), ensuring access to debt when needed [6] Market Position and Growth Potential - With a market capitalization approaching $590 billion, J&J is one of the world's largest companies, indicating stability rather than rapid wealth generation [7] - Management believes that the business could accelerate to double-digit growth by the end of this decade, suggesting potential upside for investors [7]